
    
      Estradiol vaginal tablet is indicated for use in the treatment of symptoms of atrophic
      vaginitis due to estrogen deficiency.

      This is a randomized, observer blind, parallel groups, active and placebo controlled study to
      test the clinical endpoint bioequivalence of test product (Estradiol vaginal tablet, 10mcg of
      Sun Pharmaceutical Industries Ltd. India) relative to reference (VagifemÂ®, Estradiol vaginal
      tablet, 10mcg estradiol of Novo Nordisk) in treatment of vulvar and vaginal atrophy.

      The patients will be administered with one tablet intravaginally daily for 14 days.
    
  